Floatz logo

Therapeutic Asset Ratings

200 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
4H-1-BENZOPYRAN-4-ONE, 8-.BETA.-D-GLUCOPYRANOSYL-7-HYDROXY-3-(4-HYDROXYPHENYL)-
Obesity Disorder
Ruijin HospitalP2CCC (53)
Apg-2575
Mantle Cell Lymphoma
Ruijin HospitalP2CCC (53)
Apg-2575
THL
Ruijin HospitalP2CCC (53)
Ari-0001
Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Ruijin HospitalP2CCC (53)
Ato
Mantle Cell Lymphoma (MCL)
Ruijin HospitalP2CCC (53)
Avapritinib
Acute Myeloid Leukemia
Ruijin HospitalP2CCC (53)
Cyclophosphamide
CART Therapy
Ruijin HospitalP2CCC (53)
Decitabine
Large B-Cell Lymphoma
Ruijin HospitalP2CCC (53)
Dual-Function Antibody Pd-1/Ctla-4
Pancreatic Adenocarcinoma
Ruijin HospitalP2CCC (53)
Eloxatin
Peripheral T-cell Lymphomas (PTCL)
Ruijin HospitalP2CCC (53)
Golidocitinib
Enteropathy-Associated T-Cell Lymphoma
Ruijin HospitalP2CCC (53)
Golidocitinib
Lymphoma, Extranodal NK-T-Cell
Ruijin HospitalP2CCC (53)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
CART Therapy
Ruijin HospitalP2CCC (53)
Inno-206
CART Therapy
Ruijin HospitalP2CCC (53)
Penpulimab
Locally Advanced
Ruijin HospitalP2CCC (53)
Pirtobrutinib
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Ruijin HospitalP2CCC (53)
PREDNISONE TABLETS
CART Therapy
Ruijin HospitalP2CCC (53)
Pyrotinib
B-NHL
Ruijin HospitalP2CCC (53)
Pyrotinib
CART Therapy
Ruijin HospitalP2CCC (53)
rc48-adc
B-NHL
Ruijin HospitalP2CCC (53)
rc48-adc
CART Therapy
Ruijin HospitalP2CCC (53)
Rimegepant
Large B-Cell Lymphoma
Ruijin HospitalP2CCC (53)
Ruxolitinib
Mantle Cell Lymphoma (MCL)
Ruijin HospitalP2CCC (53)
Selinexor
Lymphoma, Extranodal NK-T-Cell
Ruijin HospitalP2CCC (53)
Thymalfasin
Pancreatic Ductal Adenocarcinoma
Ruijin HospitalP2CCC (53)
Showing 76 to 100 of 200 assets
PreviousPage 4 of 8Next